Cargando…
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China
BACKGROUND: Little is known about COVID-19 outside Hubei. The aim of this paper was to describe the clinical characteristics and imaging manifestations of hospitalized patients with confirmed COVID-19 infection in Wenzhou, Zhejiang, China. METHODS: In this retrospective cohort study, 149 RT-PCR conf...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102539/ https://www.ncbi.nlm.nih.gov/pubmed/32112884 http://dx.doi.org/10.1016/j.jinf.2020.02.016 |
_version_ | 1783511848915566592 |
---|---|
author | Yang, Wenjie Cao, Qiqi Qin, Le Wang, Xiaoyang Cheng, Zenghui Pan, Ashan Dai, Jianyi Sun, Qingfeng Zhao, Fengquan Qu, Jieming Yan, Fuhua |
author_facet | Yang, Wenjie Cao, Qiqi Qin, Le Wang, Xiaoyang Cheng, Zenghui Pan, Ashan Dai, Jianyi Sun, Qingfeng Zhao, Fengquan Qu, Jieming Yan, Fuhua |
author_sort | Yang, Wenjie |
collection | PubMed |
description | BACKGROUND: Little is known about COVID-19 outside Hubei. The aim of this paper was to describe the clinical characteristics and imaging manifestations of hospitalized patients with confirmed COVID-19 infection in Wenzhou, Zhejiang, China. METHODS: In this retrospective cohort study, 149 RT-PCR confirmed positive patients were consecutively enrolled from January 17th to February 10th, 2020 in three tertiary hospitals of Wenzhou. Outcomes were followed up until Feb 15th, 2020. FINDINGS: A total of 85 patients had Hubei travel/residence history, while another 49 had contact with people from Hubei and 15 had no traceable exposure history to Hubei. Fever, cough and expectoration were the most common symptoms, 14 patients had decreased oxygen saturation, 33 had leukopenia, 53 had lymphopenia, and 82 had elevated C-reactive protein. On chest computed tomography (CT), lung segments 6 and 10 were mostly involved. A total of 287 segments presented ground glass opacity, 637 presented mixed opacity and 170 presented consolidation. Lesions were more localized in the peripheral lung with a patchy form. No significant difference was found between patients with or without Hubei exposure history. Seventeen patients had normal CT on admission of these, 12 had negative findings even10 days later. INTERPRETATION: Most patients presented with a mild infection in our study. The imaging pattern of multifocal peripheral ground glass or mixed opacity with predominance in the lower lung is highly suspicious of COVID-19 in the first week of disease onset. Nevetheless, some patients can present with a normal chest finding despite testing positive for COVID-19. Funding: We did not receive any fundings. |
format | Online Article Text |
id | pubmed-7102539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71025392020-03-31 Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China Yang, Wenjie Cao, Qiqi Qin, Le Wang, Xiaoyang Cheng, Zenghui Pan, Ashan Dai, Jianyi Sun, Qingfeng Zhao, Fengquan Qu, Jieming Yan, Fuhua J Infect Article BACKGROUND: Little is known about COVID-19 outside Hubei. The aim of this paper was to describe the clinical characteristics and imaging manifestations of hospitalized patients with confirmed COVID-19 infection in Wenzhou, Zhejiang, China. METHODS: In this retrospective cohort study, 149 RT-PCR confirmed positive patients were consecutively enrolled from January 17th to February 10th, 2020 in three tertiary hospitals of Wenzhou. Outcomes were followed up until Feb 15th, 2020. FINDINGS: A total of 85 patients had Hubei travel/residence history, while another 49 had contact with people from Hubei and 15 had no traceable exposure history to Hubei. Fever, cough and expectoration were the most common symptoms, 14 patients had decreased oxygen saturation, 33 had leukopenia, 53 had lymphopenia, and 82 had elevated C-reactive protein. On chest computed tomography (CT), lung segments 6 and 10 were mostly involved. A total of 287 segments presented ground glass opacity, 637 presented mixed opacity and 170 presented consolidation. Lesions were more localized in the peripheral lung with a patchy form. No significant difference was found between patients with or without Hubei exposure history. Seventeen patients had normal CT on admission of these, 12 had negative findings even10 days later. INTERPRETATION: Most patients presented with a mild infection in our study. The imaging pattern of multifocal peripheral ground glass or mixed opacity with predominance in the lower lung is highly suspicious of COVID-19 in the first week of disease onset. Nevetheless, some patients can present with a normal chest finding despite testing positive for COVID-19. Funding: We did not receive any fundings. The British Infection Association. Published by Elsevier Ltd. 2020-04 2020-02-26 /pmc/articles/PMC7102539/ /pubmed/32112884 http://dx.doi.org/10.1016/j.jinf.2020.02.016 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Yang, Wenjie Cao, Qiqi Qin, Le Wang, Xiaoyang Cheng, Zenghui Pan, Ashan Dai, Jianyi Sun, Qingfeng Zhao, Fengquan Qu, Jieming Yan, Fuhua Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China |
title | Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China |
title_full | Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China |
title_fullStr | Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China |
title_full_unstemmed | Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China |
title_short | Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China |
title_sort | clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (covid-19):a multi-center study in wenzhou city, zhejiang, china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102539/ https://www.ncbi.nlm.nih.gov/pubmed/32112884 http://dx.doi.org/10.1016/j.jinf.2020.02.016 |
work_keys_str_mv | AT yangwenjie clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT caoqiqi clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT qinle clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT wangxiaoyang clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT chengzenghui clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT panashan clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT daijianyi clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT sunqingfeng clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT zhaofengquan clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT qujieming clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina AT yanfuhua clinicalcharacteristicsandimagingmanifestationsofthe2019novelcoronavirusdiseasecovid19amulticenterstudyinwenzhoucityzhejiangchina |